Daly Kheireddine Mrad, Chaker Kays, Rhouma Sami Ben, Chehida Mohamed Ali Ben, Ouanes Yassine, Sellami Ahmed, Nouira Yassine
Service d'Urologie, Hôpital La Rabta, Faculté de Médecine de Tunis, Université de Tunis, El Manar, Tunisie.
Pan Afr Med J. 2019 Mar 8;32:109. doi: 10.11604/pamj.2019.32.109.17690. eCollection 2019.
Extracorporeal shock wave lithotripsy-related pain is the largest limiting factor in this technique. Our study aimed to compare the effectiveness of different types of analgesics for pain management used during ESWL sessions. We conducted a prospective study of 300 patients with urinary lithiasis justifying ESWL treatment. The patients were randomized to three groups: group I, included 100 patients who received intramuscular injection of 2cc of physiological saline solution (placebo), group II included 100 patients who received intramuscular injection of ketoprofen 100mg while group III included 100 patients who received lidocaine and prilocaine topical cream. Visual Analog Scale (VAS) was used to assess pain 10 minutes after and at the end of the session. Mean VAS score 10 minutes after and at the end of ESWL session was 3.7 and 4.91 respectively. There was no significant difference among the three groups with respect to: epidemiological data (age, sex, BMI, patient's history) and the characteristics of the renal stone (side, size, location, presence or not of double-J ureteral catheter). Eleven patients in the Group I terminated treatment early, with a significant difference compared to the other groups (p=0.003). VAS score 10 minutes after and at the end of ESWL session was statistically higher in Group I compared to Groups II and III (p < 0.001). Moreover, ESWL session was significantly more effective in Groups (II and III) compared to Group I (p<0.001). Pain treatment is necessary during ESWL sessions. Two painkillers molecules were assessed, which showed good pain control as well as an increase in the effectiveness of lithotripsy.
体外冲击波碎石术相关疼痛是该技术最大的限制因素。我们的研究旨在比较不同类型镇痛药在体外冲击波碎石术(ESWL)治疗期间用于疼痛管理的有效性。我们对300例有体外冲击波碎石术治疗指征的尿石症患者进行了一项前瞻性研究。患者被随机分为三组:第一组包括100例接受肌肉注射2毫升生理盐水溶液(安慰剂)的患者,第二组包括100例接受肌肉注射100毫克酮洛芬的患者,而第三组包括100例接受利多卡因和丙胺卡因外用乳膏的患者。使用视觉模拟评分法(VAS)在治疗后10分钟和治疗结束时评估疼痛。体外冲击波碎石术治疗后10分钟和结束时的平均VAS评分分别为3.7和4.91。三组在以下方面无显著差异:流行病学数据(年龄、性别、体重指数、患者病史)和肾结石的特征(侧别、大小、位置、是否存在双J输尿管导管)。第一组有11例患者提前终止治疗,与其他组相比有显著差异(p = 0.003)。与第二组和第三组相比,第一组在体外冲击波碎石术治疗后10分钟和结束时的VAS评分在统计学上更高(p < 0.001)。此外,与第一组相比,第二组和第三组的体外冲击波碎石术治疗效果显著更好(p<0.001)。体外冲击波碎石术治疗期间疼痛治疗是必要的。评估了两种止痛分子,它们显示出良好的疼痛控制以及碎石术有效性的提高。